Spinal intramedullary hemangioblastoma is a highly vascular tumor that accounts for 2% of all central nervous system tumors and 5% of intramedullary spinal cord tumors. It can occur sporadically or in association with von Hippel-Lindau syndrome (VHL), an autosomal dominant genetic disorder characterized by the development of multiple vascular tumor [5,6,9,12,14,19]. Despite being the treatment of choice, surgical management of these tumors remains challenging due to complex anatomy of the spinal cord and the tumor’s intimate relationship with surrounding neural structures [22].

The main objective of surgical intervention is complete tumor resection to relieve cord compression, eliminate the mass of abnormal vascular growth, and ultimately prevent or reverse neurological decline. However, the achievement of this objective is not without potential risks. Due to the tumor’s high vascularization and location within the spinal cord, coagulation during surgery may cause injury to spinal cord tissue itself or lead to coagulation of vital vessels supplying the spinal cord [13,16,29]. Outcomes for patients with hemangioblastoma are typically influenced by factors such as preoperative functional status, large tumor size, ventrally located tumor, peri-tumor syrinx, and the presence of VHL syndrome [10,18]. The location of the tumor within the spinal cord is a crucial yet frequently understudied factor in determining surgical outcomes. It is known that, the location of hemangioblastoma, particularly in relation to anterior spinal artery (ASA) feeders, has a substantial impact on neurological outcomes following surgery [34].

There were 25 surgeries performed for 23 patients. All surgical procedures were performed using a posterior approach. After executing a laminectomy at the proper level, the dura was opened, and the tumor was removed using appropriate techniques. If the tumors are embedded within the spinal cord, they are accessed via a longitudinal myelotomy. Only one case involved a subtotal resection. Total resection was achieved for the remaining 24 cases. There were no surgical complications, such as postoperative hematoma or cerebrospinal fluid leakage. The average age of patients was 44.4 years (range, 20–80). Females accounted for 68%. Eight cases (32.0%) were genetically confirmed to have VHL syndrome. Four cases (16%) exhibited neurological deterioration 1 year after surgery, while 11 cases (44.0%) exhibited neurological improvement. Twenty cases (80%) were dorsal intramedullary (IM) tumors, and five cases (20.0%) were ventral IM tumors. Syrinx was observed in 24 cases (96.0%) (Table 1). Regardless of the tumor location, the median duration of symptoms was about 12 months.

Before surgery, two (8%) and 18 cases (72%) were categorized as MMCS grade I and grade II, respectively, with most patients exhibiting modest neurological symptoms. In addition, three cases (12%) were categorized as MMCS grade III and two cases (8%) were categorized as MMCS grade IV. Before undergoing surgery, 56%, 20%, 64%, and 8% of patients complained of pain, sensory dysfunction, motor weakness, and sphincter dysfunction, respectively. At 1 year after surgery, nine cases (36%) exhibited neurological improvement, four cases (16.0%) exhibited neurological deterioration, and 12 cases (48.0%) showed no neurological change (Fig. 1).

This study provides a comprehensive analysis of prognostic factors influencing postoperative outcomes of spinal intradural hemangioblastoma, with a particular focus on tumor location within the spinal cord. Dorsal IM cases accounted for 80% of the total cases, no decrease in the MMCS was observed. Studies of dorsally located hemangioblastomas have reported favorable outcomes, with postoperative neurologic deterioration ranging from 0% to 18% [10]. Reportedly, 93% to 100% of hemangioblastomas are located on the dorsal aspect, with more than two-thirds located in the root entry zone of the dorsal root [15]. These tumors are predominantly of pial origin, accumulating around dorsal nerve rootlets or blood vessels. They are frequently encapsulated. Patients with hemangioblastomas located dorsally typically present with sensory changes as initial symptoms, suggesting that these tumors are often diagnosed before they reach a substantial size [21,32]. While numerous studies have indicated that preoperative embolization can be advantageous, our series did not include any cases of dorsal IM that underwent preoperative embolization. However, proper embolization can help preemptively mitigate the risk of intraoperative bleeding. Particularly, embolization of the dorsal artery poses less risk than that of the ASA, offering a distinct advantage [1,28].

In contrast, our cases of ventral hemangioblastomas are typically fed by the ASA. Thus, they require manipulation of the anterior part of the cord for removal, which has been associated with poor surgical outcomes in multiple studies. Characteristics of hemangioblastomas in patients with VHL disease are also referred to as “spinal leptomeningeal hemangioblastomasis”. Although the precise pathogenesis remains unclear, it is known that lesions can occur in atypical locations. Notably, all three patients with ventral hemangioblastomas reported by Van Der Veken et al. [30] were diagnosed with VHL, as were the eight patients with ventral hemangioblastomas studied by Pluta et al. [23]. Ventral hemangioblastomas have been reported to result in worse outcomes in 33% to 80% of cases, likely due to their association with the ASA and the difficulty of surgical access [15,23]. Feeding arteries and drainage veins associated with the tumor are not readily visible in a posterior approach, leading to attempts to use an anterior approach. Pluta et al. [23] have reported better clinical outcomes with an anterior approach to the tumor following corpectomy in eight cases of ventrally located hemangioblastomas. However, Van der Veken et al. [30] have reported the use of a posterior approach for removing ventral hemangioblastomas in three cases, arguing that this approach could avoid motor deficits caused by anterior myelotomy and that it is safer because one ASA supplies two-thirds of the cord’s blood supply, while two posterior spinal arteries supply the remaining third [8,17]. However, all cases in their report involved small-sized tumors accompanied by cysts. Thus, it is uncertain whether their findings could be applied to our cases.

Along with tumor size, VHL, and anterior location, syrinx is one of the factors associated with deterioration that has been studied [10,18]. Although our study showed no association with neurologic deterioration (neurologic stable vs. deterioration : 95.2% vs. 50%, p=0.09), we believe that the presence of peritumoral syrinx around the tumor may be a factor associated with surgical outcome because it facilitates and safely separates the spinal cord from the tumor during surgery.

One of our five cases of ventral hemangioblastoma did not have a feeder from the ASA, making embolization and removal relatively safe. However, feeder from the ASA was present, and embolization could not be performed due to the risk of fatal anterior cord syndrome in the remaining three cases. Interestingly, all patients with feeders from the ASA were diagnosed with VHL disease. In addition, tumor sizes ranged from 11 to 44 mm in tumor axial size, relatively larger than tumors in other locations. This suggests that tumors growing anteriorly might not be detected until they have grown large enough to affect the lateral or posterior tracts responsible for pain or sensory changes. In our series, ventral IM tumors were located between T9 and T12, making it difficult to consider an anterior approach [33]. As with other studies, poor clinical outcomes observed in our study were likely to be influenced by these factors. For ventrally located spinal cord tumors, techniques such as cord rotation by dentate ligamental stay suture and transpedicular approach can be used [11,31]. It is necessary to conduct additional research on these surgical techniques. There are also positive reports on stereotactic radiosurgery for spinal hemangioblastomas, which could be considered an alternative in cases where significant neurological deterioration following surgery is strongly anticipated [4,7,20,24].

In many studies, surgical IM hemangioblastomas is recommended for patients presenting with neurological symptoms [27]. However, there is debate regarding the timing of surgery for asymptomatic sporadic IM hemangioblastomas, with some opinions suggesting that surgical resection should be considered even in the absence of symptoms, while others have recommended surgery once symptoms associated with the lesion emerge [3,25]. For asymptomatic patients with VHL disease who have IM hemangioblastomas, surgery is generally advised when radiological evidence of tumor enlargement is detected [26]. According to our findings, factors such as tumor size and the possibility of preoperative embolization should be considered to predict the outcomes of surgery and assess the benefits of surgical resection in deciding on the timing of the surgery. Additionally, in patients with VHL disease having IM hemangioblastomas, there may be an association with feeders from the ASA, which might not be amenable to embolization. Therefore, it is essential to discuss the potential for neurological deterioration after surgery in advance.

Limitations of this study are the limited number of cases, particularly for ventral hemangioblastomas, the retrospective nature of this study, and potential selection bias. Although it might be difficult to generalize the results of this study due to its small sample size, this research aimed to analyze surgical deterioration cases, providing a deeper understanding of how tumor location could affect surgical outcomes and guide surgical planning and prognosis. To accurately analyze the characteristics and clinical outcomes of ventral spinal hemangioblastomas, multinational and/or multi-institutional research studies are needed. In addition to the advancement of genetic research and treatments, there is a need to investigate genetic therapeutic approaches.

In intramedullary spinal cord hemangioblastomas, cases located ventrally showed more frequent neurological deterioration following surgery than those located dorsally. Ventrally located hemangioblastomas were greater in size than those in other locations. They were mostly supplied by the ASA in VHL patients.